Explore RLT services
Explore RLT Services
At Novartis, we strive to deliver innovative treatments to eligible patients through targeted nuclear medicine. Yet, the journey to deliver RLT can be long and complex for prescribing and treating healthcare professionals (HCPs).
Novartis’ services aim to simplify the RLT journey and minimise time to treatment, helping ensure eligible patients can begin therapy.
RLT Education
HCP and patient resources to support RLT treatment
RLT Schedule
Streamlining the RLT referral, scheduling and delivery process
RLT Supply
Providing transparent and timely RLT treatment deliveries to UK treatment centres
RLT Education
Empowering you and your team with the latest education and training on radioligand imaging and RLT so you feel confident in delivering patient care
Your eligible patients prescribed with RLT and their caregivers will be provided with the education and support to navigate their treatment journey with hope and reassurance.
Your dedicated Novartis representative can equip you and your team with the latest education and resources to help you with prescribing RLT as a treatment option for eligible patients.
Patient education materials, developed and funded by Novartis, are available for eligible patients who are prescribed a Novartis RLT to support their treatment journey
RLT Schedule
Streamlining the referral, scheduling and delivery process to ensure timely access to therapies is essential, because every moment counts for eligible patients
Certain Novartis RLT products can be delivered to treating centres 5 days a week.
Last-minute first-dose deliveries are available for certain products, eligible patients and to reduce waste. Please contact your local Novartis representative for more information.
Ability to schedule all future doses for eligible patients, with the flexibility to make changes up to 7 days prior to delivery – helping you better plan upcoming treatments.
Click to contact your Novartis Account Manager
RLT Supply
Providing supply and real-time delivery, powered by our global manufacturing footprint, means your eligible patients receive treatment when they need it
Each patient dose is shipped from our manufacturing sites in Europe within 7–14 days.
From supply to transportation and packaging, we prioritise minimising our environmental impact while maximising patient service.
Our customer service team receive real-time, up-to-date tracking to ensure the transit process remains transparent and efficient, reducing patient time-to-treatment and disruption to care.
RLT Supply helps your eligible patients receive treatment when they need it most
RLT Services
Watch the video below to learn more about what our RLT services can offer you.
With your partnership, we are dedicated to enhancing and refining our services to ensure more eligible patients have access to RLT.
Learn more about the manufacturing and logistics of our RLT services
RLT Medicines
RLT Medicines
Manufacturing and logistics
Manufacturing and logistics
Find an RLT treatment centre
Find an RLT treatment centre
HCP, healthcare professional; RLT, radioligand therapy.
UK | February 2026 | FA-11482952
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.
